Bing

SEARCH HISTORY

Auxilium Pharmaceuticals (AUXL): AUXL stock is up 1.4% today. Some of the biggest losers among healthcare stocks include: Aegerion Pharmaceuticals (AEGR): AEGR stock is down 3.0% today. Edwards Lifesciences Corp (EW): EW stock is down 2.
Investor Place · 3/27/2014
For other put options contract ideas at the various different available expirations, visit the AEGR Stock Options page of StockOptionsChannel.com. In mid-afternoon trading on Thursday, the put volume among S&P 500 components was 909,581 contracts ...
Forbes · 7/31/2014
Aegerion Pharmaceuticals (NASDAQ:AEGR) is a classic example of a much hyped biotech failing to deliver on its promise. In 2013, the company promised a great deal as its lead product candidate was approved by the FDA. That year saw the stock gain …
Seeking Alpha · 5/6/2015
More from Bing News
AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced that on June 1, 2015, Aegerion granted stock options to purchase an aggregate of ...
GlobeNewswire · 6/11/2015
Aegerion Pharmaceuticals, Inc. (AEGR) released financial and operational results for the third quarter (3Q) of fiscal year 2014 (FY14) after market closed yesterday. It reported higher-than-anticipated losses on high sales growth, causing stock to plummet ...
bidnessetc.com · 10/31/2014
Needham & Company LLC restated their hold rating on shares of Aegerion Pharmaceuticals (NASDAQ:AEGR) in a report released on Tuesday. Other equities research analysts have also recently issued reports about the stock. Analysts at JPMorgan …
Mideast Times · 5/26/2015
Aegerion Pharmaceuticals, Inc. (AEGR - Analyst Report) is slated to report first-quarter ... show that Aegerion is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy ...
ZACKS · 5/1/2015
On Tuesday, Aegerion Pharmaceuticals surged 9.68% to $19.15 (AEGR has a 52 week trading range of $11.75 to $19.25 a share) for a market cap of $487.72 million plus the stock is up 14.4% since the start of the year and up 77.3% since 2010. The surge …
Smallcap Network · ByJohn Udovich · 10/17/2012